Market Capitalization (Millions $) |
153 |
Shares
Outstanding (Millions) |
7 |
Employees |
40 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-122 |
Cash Flow (TTM) (Millions $) |
91 |
Capital Exp. (TTM) (Millions $) |
0 |
Cidara Therapeutics Inc
Cidara Therapeutics Inc is a biotechnology company focused on developing and commercializing novel antifungal and immunotherapy technologies. The company's goal is to address unmet medical needs in the treatment of serious fungal infections and provide innovative solutions for patients with compromised immune systems. Cidara's proprietary technology platforms, CloudbreakTM and Immunotherapy Platforms, aim to improve patient outcomes and reduce the risks associated with existing antifungal therapies. The company is committed to advancing its pipeline of drug candidates and revolutionizing the field of infectious diseases.
Company Address: 6310 Nancy Ridge Drive, San Diego, 92121 CA
Company Phone Number: 752-6170 Stock Exchange / Ticker: NASDAQ CDTX
|